Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 25 (RPL23AP25)

Target
RPL23AP25
Molecular classification
Pseudogene (processed, refers to ribosomal protein family), Other
01

Overview

RPL23AP25 (Ribosomal protein L23a pseudogene 25) is a processed pseudogene in the human genome and does not encode a functional ribosomal protein. It is one of many dispersed genomic sequences similar to the functional ribosomal protein L23a gene (RPL23A), which encodes a component of the large 60S ribosomal subunit[4][5]. Like other ribosomal protein pseudogenes, RPL23AP25 lacks coding potential due to mutations or truncations and typically does not produce protein. There is no evidence RPL23AP25 is involved in cellular signaling, disease mechanisms, drug interactions, or serves as a clinically relevant biomarker[4][5][7]. The approved gene symbol is RPL23AP25, and it is cataloged as a pseudogene by the HUGO Gene Nomenclature Committee[4]. If you intended to refer to the functional ribosomal protein L23a (RPL23A) rather than this pseudogene, please clarify, as RPL23A itself can be relevant to ribosome biology and has related disease associations[5].

Other names
RPL23A_7_192RPL23AP25
02

Disease associations

Other

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 25 (RPL23AP25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 25 (RPL23AP25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call